Brief: Sab Biotherapeutics Files Prospectus Related To Up To 14.7 Million Shares Of Common Stock That Selling Stockholders May Sell
03/02/2023 22:10
Feb 3 (Reuters) - SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS FILES PROSPECTUS RELATED TO UP TO 14.7
MILLION SHARES OF COMMON STOCK THAT SELLING STOCKHOLDERS MAY
SELL - SEC FILING
Further company coverage: SABS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies